Article info

Download PDFPDF
Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12

Authors

  1. Correspondence to Dr Simon John Whitehead, Department of Clinical Biochemistry, New Cross Hospital, Wednesfield Rd, Wolverhampton WV10 0QP, UK; simonwhitehead{at}nhs.net
View Full Text

Citation

Whitehead SJ, Ford C, Gama RM, et al
Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12

Publication history

  • Received January 10, 2017
  • Revised April 17, 2017
  • Accepted April 18, 2017
  • First published July 22, 2017.
Online issue publication 
November 20, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.